Impact Partnership Wealth, LLC
Source: SEC Form 13F · as of Mar 2026Impact Partnership Wealth, LLC holds 21 biotech & pharma companies tracked by BioSniper, totaling $15.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$15.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 2,326 | $2.1M |
| GILDGILEAD SCIENCES, INC. | 13,693 | $1.9M |
| CAHCardinal Health Inc. | 6,699 | $1.4M |
| JNJJOHNSON & JOHNSON | 5,776 | $1.4M |
| INCYIncyte Corp. | 12,971 | $1.2M |
| CORCencora Inc. | 3,723 | $1.2M |
| MCKMcKesson Corporation | 1,119 | $968K |
| AMGNAMGEN INC | 2,618 | $921K |
| MEDPMedpace Holdings Inc. | 1,426 | $685K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,451 | $663K |
| MRKMerck & Co., Inc. | 4,578 | $551K |
| BMYBRISTOL MYERS SQUIBB CO | 8,920 | $541K |
| HALOHALOZYME THERAPEUTICS, INC. | 7,214 | $466K |
| PMPhilip Morris International Inc | 2,720 | $450K |
| ABBVAbbVie Inc. | 1,640 | $357K |
| PFEPFIZER INC | 10,400 | $292K |
| VTRSViatris Inc | 18,392 | $248K |
| IQVIQVIA Holdings Inc. | 1,295 | $221K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 461 | $206K |
| CRDLCardiol Therapeutics Inc. | 10,850 | $15K |
| CGCCanopy Growth Corp | 14,000 | $13K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.